CLOV
Clover Health Investments, Corp. (CLOV)
Last Price$3.83.0%
Market Cap$1,812.5M

CLOV Q4’24 Earnings

MetricEstimatesActualsSurprise
Revenue$347.4M$337.0M
MISS by 3.0%
EPS($0.07)($0.04)
BEAT by 31.8%

CLOV Earnings Calls

Latest CLOV Earnings Call Summary

Crunching data... Almost there!

CLOV Earnings Calls Top Focus Area

Crunching data... Almost there!

CLOV Earnings Sentiment

CLOV Earnings Sentiment Score

Crunching data... Almost there!

CLOV Earnings Sentiment & Price Performance

Crunching data... Almost there!

CLOV Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
($400.0M)($200.0M)$0.0$200.0M$400.0M$600.0M$800.0MApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$165.5M$169.1M$200.3M$427.2M$874.4M$856.8M$322.0M$306.0M$346.9M$331.0M
Value Sense
Actual Revenue
Forecast Revenue

CLOV Earnings History

Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$117.9M$117.9M$118.4M$0.0$165.5M$172.1M$169.1M($506.7M)$200.3M$412.5M$427.2M$432.0M$874.4M$846.7M$856.8M$898.8M$322.0M$320.1M$306.0M$510.3M$346.9M$356.3M$331.0M$337.0M
Revenue estimateN/AN/AN/AN/AN/AN/AN/A$167.0M$192.6M$205.4M$413.1M$408.1M$787.4M$814.6M$799.5M$785.5M$498.7M$490.8M$494.6M$474.0M$321.2M$338.8M$346.3M$347.4M
Revenue surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%403.5%4.0%100.8%3.4%5.9%11.0%3.9%7.2%14.4%35.4%34.8%38.1%7.6%8.0%5.2%4.4%3.0%
EPS actual($2.76)($2.76)($1.21)$0.00($0.07)$0.01$0.03($0.20)($0.13)($0.78)($0.08)($0.40)($0.16)($0.22)($0.16)($0.18)($0.16)($0.06)($0.09)($0.15)($0.04)$0.01($0.02)($0.04)
EPS estimateN/AN/AN/AN/AN/AN/AN/A($0.86)($0.11)($0.14)($0.23)($0.26)($0.27)($0.20)($0.22)($0.24)($0.17)($0.14)($0.11)($0.14)($0.07)($0.05)($0.04)($0.07)
EPS surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%76.6%18.9%470.7%64.1%54.7%40.4%11.7%28.7%24.8%3.9%56.8%14.8%7.6%44.7%120.6%51.1%31.8%

CLOV Price Change after Earnings

Crunching data... Almost there!

CLOV Recent Quarter Financial Statements Overview

Income statement
Balance sheet
Cash Flow statement
$337.0M (34.0%) YoY
$93.9M 50.8% YoY
27.9% margin
Cost of revenue
$243.0M (45.7%) YoY
Operating expenses
$115.4M (9.8%) YoY
Net income
$22.1M (68.7%) YoY
(6.6%) margin
Other: $21.7M
SG&A
$115.0M 4.6% YoY
34.1% of revenue

Competing with CLOV Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$1,812.5M
$1,371.1M
($0.09)
(34.0%)
(70.1%)
Miss by 2.7%
Beat by 9.7%
38.6%
(11.4%)
Beats: 8
Misses: 2
36.0%
102.8%
$466.6B
$396.6B
$15.59
8.1%
1.4%
Beat by 1.7%
Miss by 14.6%
10.6%
21.8%
Beats:
Misses:
12.8%
91.6%
$99.1B
$176.8B
$25.76
6.6%
(49.9%)
Beat by 4.5%
Miss by 80.9%
1.3%
477.3%
Beats: 8
Misses: 2
8.7%
33.7%
$89.6B
$245.3B
$12.25
28.7%
45.0%
Beat by 10.5%
Miss by 30.0%
(8.3%)
26.2%
Beats: 8
Misses: 2
2.1%
2,338.7%
$85.0B
$372.8B
$3.67
4.2%
(17.6%)
Beat by 5.4%
Miss by 8.8%
(4.8%)
23.5%
Beats: 8
Misses: 2
4.5%
61.3%
$32.3B
$117.8B
$10.01
10.4%
30.1%
Beat by 1.9%
Miss by 268.2%
10.0%
(270.6%)
Beats: 8
Misses: 2
5.7%
63.7%
$31.0B
$163.1B
($0.09)
3.4%
N/A
Beat by 7.6%
Miss by 527.4%
5.2%
(138.2%)
Beats: 8
Misses: 2
5.2%
15.1%
$18.1B
$40.6B
($0.11)
16.0%
N/A
Beat by 5.9%
Miss by 378.5%
3.7%
(137.1%)
Beats: 8
Misses: 2
8.1%
19.9%
$3,211.8M
$9,177.6M
$0.17
67.1%
(6.1%)
Beat by 2.7%
Beat by 261.7%
18.8%
(230.7%)
Beats: 5
Misses: 5
21.2%
579.6%
$3,200.8M
$2,703.6M
($0.68)
50.7%
(36.0%)
Beat by 4.7%
Beat by 45.4%
26.9%
(17.3%)
Beats: 4
Misses: 6
38.7%
(40.0%)

FAQ

1. When was Clover Health Investments, Corp.'s last earnings date?

Clover Health Investments, Corp.'s last earnings date was Dec'24 (Q4 2024).

4. What is Clover Health Investments, Corp.'s next quarter EPS estimate?

Clover Health Investments, Corp.'s next quarter EPS estimate is ($0.07), with an expected 40.0% YoY growth.